Back
Speaker illustration

Doctor Mahendra Sibartie

Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)

Presentations

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Current issues in lipid-lowering therapy

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources